Phenazolam

Phenazolam is classified as a novel benzodiazepine. Benzodiazepines are central nervous system depressants. Novel benzodiazepines, typically defined as emergent benzodiazepines not used medicinally, are often pirated from early drug discovery or pharmaceutical studies. Novel benzodiazepines have appeared on illicit drug markets in recent years and have caused adverse events, as described in the literature; fatalities linked to novel benzodiazepine use have occurred, commonly when used in combination with other depressants (e.g., opioids and alcohol). Phenazolam is structurally similar to bromazolam, triazolam, and other novel benzodiazepines. Phenazolam is not federally controlled in the United States.

Class:

Benzodiazepine

Appearance:

Blood

Formula:

C17H12BrClN4

MW:

387.7

[M+]:

386

[M+H]+:

387.0007

IUPAC:

8-bromo-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine

Report Date:

December 6, 2022